2019
DOI: 10.1111/jam.14228
|View full text |Cite
|
Sign up to set email alerts
|

Construction of a novelDNAvaccine candidate targeting F gene of genotypeVIINewcastle disease virus and chickenIL‐18 delivered bySalmonella

Abstract: Aims Genotype VII Newcastle disease (ND) is one of the most epidemic and serious infectious diseases in the poultry industry. A novel vaccine targeting VII Newcastle disease virus (NDV) is still proving elusive. Methods and Results In this study, we constructed regulated delayed lysis Salmonella strains expressing either a fusion protein (F) alone under an eukaryotic CMV promoter or together with chicken IL‐18 (chIL‐18) as a molecular adjuvant under prokaryotic Ptrc promoter, named pYL1 and pYL23 respectively.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(13 citation statements)
references
References 42 publications
(81 reference statements)
1
12
0
Order By: Relevance
“…Thus, our work demonstrates for the first time that EP can effectively improve the efficacy of NDV DNA vaccines by enhancing the immune response. Other delivery methods, including the use of liposomes, nano-chitosan or Salmonella spp as a vector, have been used to improve NDV DNA vaccines [7,11]. A DNA prime-protein booster strategy can further increase the protection rate [14].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, our work demonstrates for the first time that EP can effectively improve the efficacy of NDV DNA vaccines by enhancing the immune response. Other delivery methods, including the use of liposomes, nano-chitosan or Salmonella spp as a vector, have been used to improve NDV DNA vaccines [7,11]. A DNA prime-protein booster strategy can further increase the protection rate [14].…”
Section: Discussionmentioning
confidence: 99%
“…Using complement degradation component 3 as an adjuvant has been shown to increase the production of IgG and IgA induced by the F protein DNA vaccine, accompanied by an increased protection rate [39]. Inoculation with IL-18 and F protein together with Salmonella Typhimurium as a vector by the oral route has been shown to increase lymphocyte proliferation, but it does not promote antibody production or provide sufficient protection [7]. Viral shedding was not measured in either of the above-mentioned studies, and therefore, the impact of these approaches on shedding is not known.…”
Section: Discussionmentioning
confidence: 99%
“…Flow cytometry analysis of Lp-12-triggered T cell responses after vaccination. a The single cells in peripheral-blood were prepared as described and subjected to flow cytometry assay gating was done according to [57]. b Panels representing CD3 + CD4 + T cells for each group.…”
Section: Figmentioning
confidence: 99%
“…Single-cell suspensions from blood were prepared using a peripheral-blood lymphocyte separation kit (Solarbio, Beijing, China), and flow cytometry was performed to detect the percentages of CD3 + CD4 + , CD3 + CD8 + T-cells [57]. The isolated cells (1 × 10 6 ) were incubated with FITC-conjugated anti-chicken CD3 and PE-conjugated anti-chicken CD4 or CD8 (SouthernBiotech) monoclonal antibodies, respectively.…”
Section: Flow Cytometrymentioning
confidence: 99%
“…Cytokines play a crucial role in controlling the immune response. Previous studies have indicated that cytokines such as chicken interferon gamma (IFN-γ) [ 6 ], interferon α (IFN-α) [ 7 ], interleukin-1β (IL-1β) [ 8 , 9 ], interleukin-2 (IL-2) [ 10 ], interleukin-18 (IL-18) [ 11 , 12 , 13 , 14 ], interleukin-6 (IL-6) [ 15 ], interleukin-4 (IL-4) [ 16 ], and interleukin-15 (IL-15) could be promising adjuvants, due to their safety and high efficiency [ 17 ]. The co-administration of antigens with cytokines is a promising strategy to reduce the side-effects of adjuvants, as well as to enhance humoral and cell-mediated immune responses to promote vaccine efficacy.…”
Section: Introductionmentioning
confidence: 99%